TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/23 18:19 | 4/6/23 | PRLD | Prelude Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Huang Jane | DE | O | P,CMO | S.d | -81 | 6.12 | 0 | -13 | -35 | 24 | D | ||||||||||||||
12/16/21 17:50 | 12/14/21 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Huang Jane | E9 | O | CMO,Hema | S.d | -417 | 278.14 | 0 | -2 | -1 | 160 | D | |||||||||||||||
12/2/21 18:21 | 12/1/21 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Huang Jane | E9 | O | CMO,Hema | S | -377 | 359.86 | 0 | -1 | -1 | 160 | D | |||||||||||||||
11/19/21 18:18 | 11/17/21 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Huang Jane | E9 | O | CMO,Hema | S.d | -572 | 381.34 | 0 | -2 | -1 | 145 | D | |||||||||||||||
10/21/21 17:37 | 10/19/21 | BGNE | Beigene, Ltd. | Health | Drug | Pharmaceutical Preparations | Huang Jane | E9 | O | CMO,Hema | S.d | -559 | 372.78 | 0 | -2 | -1 | 145 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |